Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Binding of [3H]Amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene to Rat Striatal Membranes

Effects of Purine Nucleotides and Ultraviolet Irradiation

NANCY R. ZAHNISER, KIM A. HEIDENREICH and PERRY B. MOLINOFF
Molecular Pharmacology May 1981, 19 (3) 372-378;
NANCY R. ZAHNISER
Department of Pharmacology, University of Colorado Health Sciences Center, Denver, Colorado 80262
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KIM A. HEIDENREICH
Department of Pharmacology, University of Colorado Health Sciences Center, Denver, Colorado 80262
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PERRY B. MOLINOFF
Department of Pharmacology, University of Colorado Health Sciences Center, Denver, Colorado 80262
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The binding of the rigid dopamine analogue [3H]amino-6,7-dihydroxy-1,2,3,4-tetrahydronapthalene ([3H]ADTN) to rat striatal membranes was characterized in the presence and absence of purine nucleotides. At 37°, when assays were carried out in the presence of ATP or GTP, the binding of [3H]ADTN increased for approximately 5 min and then progressively declined. However, when assays were carried out at 20°, [3H]ADTN binding reached equilibrium and was stable in both the absence and presence of purine nucleotides. Scatchard analysis of binding isotherms showed that the affinity of the binding sites for [3H]ADTN decreased by approximately 3-fold in the presence of either 0.3 mM ATP or GTP. An unexpected finding was that the density of binding sites increased by approximately 5-fold. In contrast, the nonhydrolyzable purine nucleotide analogues guanylylimidodiphosphate and adenylylimidodiphosphate did not affect the binding of [3H]ADTN. The pharmacological specificity of [3H]ADTN binding, determined either in the absence or presence of ATP or GTP, was characteristic of binding to dopamine receptors in that dopamine, epinine, and (±)-ADTN were more potent than (-)-norepinephrine or (-)-epinephrine in inhibiting [3H]ADTN binding, and binding was inhibited by a variety of neuroleptics including (+)-butaclamol and (α)-flupenthixol. However, there were effects of purine nucleotides on the affinities of the receptor for the partial agonist apomorphine and for a variety of antagonists. In the presence of nucleotides, antagonists were 2 to 10 times less potent in inhibiting [3H]ADTN binding, whereas apomorphine was 300-fold less potent. Exposure of striatal membranes to UV irradiation (λmax = 310 nm) for 30 min reduced [3H]ADTN binding observed in the absence of nucleotide by 60% and eliminated the increase in binding observed in the presence of nucleotide. Neither [3H]spiroperidol binding nor dopamine- or ADTN-stimulated adenylate cyclase activity was affected by this treatment. The results suggest that, in the presence of ATP or GTP, [3H]ADTN binds to a second class of binding sites in the striatum. These additional sites (Bmax ∼ 20 pmoles/mg of protein) are not associated with either [3H]spiroperidol binding or dopamine-stimulated adenylate cyclase activity.

ACKNOWLEDGMENTS We thank Ms. Candace Collamer for excellent secretarial assistance and Drs. Barry Wolfe, Ken Minneman, Rita Huff, Rick Rabin, and Greg Weiland for their helpful discussions. Dr. James Maller generously donated the Walsh inhibitor.

  • Copyright © 1981 by The American Society for Pharmacology and Experimental Therapeutics

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 19, Issue 3
1 May 1981
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Binding of [3H]Amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene to Rat Striatal Membranes
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Binding of [3H]Amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene to Rat Striatal Membranes

NANCY R. ZAHNISER, KIM A. HEIDENREICH and PERRY B. MOLINOFF
Molecular Pharmacology May 1, 1981, 19 (3) 372-378;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Binding of [3H]Amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene to Rat Striatal Membranes

NANCY R. ZAHNISER, KIM A. HEIDENREICH and PERRY B. MOLINOFF
Molecular Pharmacology May 1, 1981, 19 (3) 372-378;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • α-Conotoxin Binding Site on the GABAB Receptor
  • Upacicalcet binds to the amino acid binding site of CaSR
  • Characterization of GRD and LCCH3 from Human Louse
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics